Cargando…

Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials

BACKGROUND: The incidence and prevalence of chronic diseases have reached epidemic proportions during the last decades and are not expected to diminish. Chronic diseases increasingly affect younger individuals too, with over 40% of all deaths due to non-communicable diseases occurring before the age...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Kelly F. J., Wesselius, Anke, Schols, Annemie M. W. J., Zeegers, Maurice P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907695/
https://www.ncbi.nlm.nih.gov/pubmed/29673375
http://dx.doi.org/10.1186/s13063-018-2630-7
_version_ 1783315586395144192
author Stewart, Kelly F. J.
Wesselius, Anke
Schols, Annemie M. W. J.
Zeegers, Maurice P.
author_facet Stewart, Kelly F. J.
Wesselius, Anke
Schols, Annemie M. W. J.
Zeegers, Maurice P.
author_sort Stewart, Kelly F. J.
collection PubMed
description BACKGROUND: The incidence and prevalence of chronic diseases have reached epidemic proportions during the last decades and are not expected to diminish. Chronic diseases increasingly affect younger individuals too, with over 40% of all deaths due to non-communicable diseases occurring before the age of 70. This has led to the development of information services aimed at preventive health care, such as Health Potential®. This counselling service estimates a personal disease risk of a carefully selected list of preventable common chronic diseases that have both a genetic and a lifestyle component of development. The results are delivered face-to-face by a lifestyle counsellor, simultaneously stimulating initial steps towards behaviour change. This information can assist in lifestyle decision-making. METHODS/DESIGN: The primary aim is to study the effect of the Health Potential® service on change in lifestyle behaviour in distinguishable customer populations. The secondary aims are (1) to study the effect of the Health Potential® service on determinants of behaviour change, (2) to study the effect of additional lifestyle counselling on behaviour change and determinants thereof, and (3) to describe the characteristics of the Health Potential® customer. The study consists of two integrated designs: (A) a two-armed non-randomised controlled pre-test/post-test trial (1.5:1 ratio), followed by (B) a two-armed randomised controlled pre-test/post-test trial (1:1 ratio), resulting in three study arms. Participants are clients of local prevention clinics, purchasing a personalised health check (PHC; intervention condition), consisting of Health Potential® and a general health check, or the general health check alone (GHC; control condition) (part A). PHC participants will be randomised to receive four additional lifestyle counselling sessions over a period of 3 months (part B). DISCUSSION: This research can provide valuable insights into the effectiveness of and possible ways forward in the field of personalised prevention making use of lifestyle interventions enriched with modern genetic advancements. TRIAL REGISTRATION: Nederlands Trial Register, NTR6289 and NTR6288. Registered on 24 February 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2630-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5907695
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59076952018-04-30 Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials Stewart, Kelly F. J. Wesselius, Anke Schols, Annemie M. W. J. Zeegers, Maurice P. Trials Study Protocol BACKGROUND: The incidence and prevalence of chronic diseases have reached epidemic proportions during the last decades and are not expected to diminish. Chronic diseases increasingly affect younger individuals too, with over 40% of all deaths due to non-communicable diseases occurring before the age of 70. This has led to the development of information services aimed at preventive health care, such as Health Potential®. This counselling service estimates a personal disease risk of a carefully selected list of preventable common chronic diseases that have both a genetic and a lifestyle component of development. The results are delivered face-to-face by a lifestyle counsellor, simultaneously stimulating initial steps towards behaviour change. This information can assist in lifestyle decision-making. METHODS/DESIGN: The primary aim is to study the effect of the Health Potential® service on change in lifestyle behaviour in distinguishable customer populations. The secondary aims are (1) to study the effect of the Health Potential® service on determinants of behaviour change, (2) to study the effect of additional lifestyle counselling on behaviour change and determinants thereof, and (3) to describe the characteristics of the Health Potential® customer. The study consists of two integrated designs: (A) a two-armed non-randomised controlled pre-test/post-test trial (1.5:1 ratio), followed by (B) a two-armed randomised controlled pre-test/post-test trial (1:1 ratio), resulting in three study arms. Participants are clients of local prevention clinics, purchasing a personalised health check (PHC; intervention condition), consisting of Health Potential® and a general health check, or the general health check alone (GHC; control condition) (part A). PHC participants will be randomised to receive four additional lifestyle counselling sessions over a period of 3 months (part B). DISCUSSION: This research can provide valuable insights into the effectiveness of and possible ways forward in the field of personalised prevention making use of lifestyle interventions enriched with modern genetic advancements. TRIAL REGISTRATION: Nederlands Trial Register, NTR6289 and NTR6288. Registered on 24 February 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2630-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-19 /pmc/articles/PMC5907695/ /pubmed/29673375 http://dx.doi.org/10.1186/s13063-018-2630-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Stewart, Kelly F. J.
Wesselius, Anke
Schols, Annemie M. W. J.
Zeegers, Maurice P.
Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title_full Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title_fullStr Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title_full_unstemmed Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title_short Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
title_sort stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907695/
https://www.ncbi.nlm.nih.gov/pubmed/29673375
http://dx.doi.org/10.1186/s13063-018-2630-7
work_keys_str_mv AT stewartkellyfj stagesofbehaviouralchangeafterdirecttoconsumerdiseaseriskprofilingstudyprotocoloftwointegratedcontrolledpragmatictrials
AT wesseliusanke stagesofbehaviouralchangeafterdirecttoconsumerdiseaseriskprofilingstudyprotocoloftwointegratedcontrolledpragmatictrials
AT scholsannemiemwj stagesofbehaviouralchangeafterdirecttoconsumerdiseaseriskprofilingstudyprotocoloftwointegratedcontrolledpragmatictrials
AT zeegersmauricep stagesofbehaviouralchangeafterdirecttoconsumerdiseaseriskprofilingstudyprotocoloftwointegratedcontrolledpragmatictrials